Geographical source of SARS-CoV-2 sequence data
The world map and table below provide a snapshot of the number of SARS-CoV-2 raw sequences submitted by country.
The original source of data is the COVID-19 Data Portal statistics section.
Country |
Raw sequences submitted |
United Kingdom |
1,057,489 |
USA |
484,219 |
Ireland |
33,473 |
Spain |
22,135 |
Australia |
15,629 |
VEO consortium reports
The VEO consortium (Versatile Emerging infectious disease Observatory) submits monthly reports to the European Commission on mutations and variation in publicly shared SARS-CoV-2 raw sequencing data.
You can browse all previous VEO reports in the table below.
If you would like to receive the VEO reports straight to your inbox, please send an email to veo.europe@erasmusmc.nl with ‘VEO COVID-19 Report’ in the subject line.
Genomic resources
NextSpain COVID-19 shows the results obtained from the analysis of complete genome sequences of SARS-CoV-2 deposited in GISAID or other publicly accessible databases. The analyses are performed with the NextStrain engine to inform the scientific community and the general public about the genomic epidemiology of COVID-19 in Spain: SeqCOVID Genomic epidemiology of COVID-19 in Spain. The epidemiological map is built with this code and it is mantained by FISABIO Sequencing and Bioinformatics Service and Tuberculosis Genomics Unit (IBV-CSIC).
{{ partial "genomics/nextspain-iframe.html" }}
This map is part of the project "Sequencing of the SARS-CoV-2 virus genome for the monitoring and management of the COVID-19 epidemic in Andalusia and the rapid generation of prognostic and response to treatment biomarkers". The consortium is made up of 14 hospitals and 5 Health Research Institutes from the Andalusia region, the Technical Office for Information Management, the Regional Management of Public Health (Epidemiological Surveillance and Occupational Health Service) and the Fundación Progreso y Salud (FPS). The epidemilogical map has been developed and is maintained by the Clinical Bioinformatics Area at the FPS.
This section will be periodically updated with new genomic resources when available.